IMPRESS is impressing

摘要

The discovery of EGFR mutations in patients with NSCLC has dramatically changed the treatment of NSCLC in recent years. Deletions in exon 19 and the L858R point mutation on exon 21 are the most common mutations which occurred in the tyrosine kinase domain of the EGFR gcne[1].